Essential Partners’s Journey Medical DERM Stock Holding History

Essential Partners’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$142	Buy	+20	New	+$114	﹤0.01%	2699

Other funds holding DERM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Capital Management

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return

Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Essential Partners's DERM Position: Q2 2026 in Review

Essential Partners opened a new position in Journey Medical (DERM) in Q2 2026: 20 shares worth $142. The stake represents ﹤0.01% of the portfolio and ranks #2699 among its holdings.

71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

Essential Partners held 20 shares of Journey Medical worth $142 as of Q2 2026.
Journey Medical was a new Essential Partners position in Q2 2026.
Journey Medical made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2699 holding.
71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.